FSTL1 and myocardial infarction: Wei and colleagues showed in mouse and swine MI models that epicardial FSTL1 declines following injury and its restoration through local injection of human FSTL1 by a bioengineered epicardial patch resulted in improved cardiac function, increased vessel formation, and increased cardiomyocyte proliferation [21].